Chemed (CHE) to Release Earnings on Thursday

Key Points

• Q1 2026 results are due after the market close on Thursday, April 23; analysts expect EPS of $5.39 and revenue of $659.223 million, and Chemed has set FY 2026 guidance at $23.25–$24.25 EPS with an earnings call scheduled for April 24 at 10:00 AM ET.
• In the prior quarter (reported Feb. 25) Chemed missed estimates, delivering $6.42 EPS versus $7.02 expected and $639.34 million in revenue versus $659.09 million, while analysts project roughly $21 EPS for the current fiscal year and $23 for the next.
• The stock trades with a market cap of about $5.52 billion, a P/E of ~20.6 and a 0.6% yield; the CEO sold 2,000 shares in March and analyst ratings are mixed, with a consensus "Hold" and a $498 price target.

Chemed (NYSE:CHE - Get Free Report) will likely be releasing its Q1 2026 results after the market closes on Thursday, April 23rd. Analysts expect the company to announce earnings of $5.39 per share and revenue of $659.2230 million for the quarter. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Investors are encouraged to explore the company's upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Friday, April 24, 2026 at 10:00 AM ET.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing analysts' consensus estimates of $7.02 by ($0.60). The firm had revenue of $639.34 million for the quarter, compared to analysts' expectations of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.The firm's revenue for the quarter was down .1% on a year-over-year basis. During the same period last year, the business earned $6.83 earnings per share. On average, analysts expect Chemed to post $21 EPS for the current fiscal year and $23 EPS for the next fiscal year.

Chemed Stock Performance

Shares of NYSE CHE opened at $377.75 on Thursday. The business has a 50 day simple moving average of $413.08 and a 200 day simple moving average of $428.97. Chemed has a 52 week low of $365.20 and a 52 week high of $593.80. The stock has a market cap of $5.52 billion, a price-to-earnings ratio of 20.56, a PEG ratio of 1.49 and a beta of 0.49.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were paid a $0.60 dividend. The ex-dividend date was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed's payout ratio is 13.06%.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total value of $806,360.00. Following the transaction, the chief executive officer directly owned 93,719 shares of the company's stock, valued at $37,785,626.42. The trade was a 2.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 3.29% of the stock is owned by company insiders.

Institutional Investors Weigh In On Chemed

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Los Angeles Capital Management LLC acquired a new position in Chemed during the 4th quarter valued at $26,000. Global Retirement Partners LLC grew its position in Chemed by 200.0% in the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company's stock worth $37,000 after purchasing an additional 58 shares during the last quarter. Geneos Wealth Management Inc. grew its position in Chemed by 330.4% in the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company's stock worth $61,000 after purchasing an additional 76 shares during the last quarter. Employees Retirement System of Texas acquired a new stake in Chemed in the 3rd quarter worth $64,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of Chemed by 5,333.3% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 163 shares of the company's stock worth $73,000 after purchasing an additional 160 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. Royal Bank Of Canada restated a "sector perform" rating and set a $422.00 price target (down from $572.00) on shares of Chemed in a research note on Friday, February 27th. Weiss Ratings lowered shares of Chemed from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday. Jefferies Financial Group cut shares of Chemed from a "buy" rating to a "hold" rating in a report on Thursday, January 22nd. Zacks Research downgraded shares of Chemed from a "hold" rating to a "strong sell" rating in a research report on Wednesday, March 4th. Finally, Oppenheimer cut their target price on Chemed from $580.00 to $500.00 and set an "outperform" rating on the stock in a report on Friday, February 27th. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $498.00.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.